+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The neuroimaging center of the Pediatric Brain Tumor Consortium - Collaborative neuroimaging in pediatric brain tumor research: A work in progress



The neuroimaging center of the Pediatric Brain Tumor Consortium - Collaborative neuroimaging in pediatric brain tumor research: A work in progress



AJNR 28(4): 603-607



As an essential part of the National Cancer Institute (NCI)-funded Pediatric Brain Tumor Consortium (PBTC), the Neuroimaging Center (NIC) is dedicated to infusing the study of pediatric brain tumors with imaging "best practice" by producing a correlative research plan that 1) resonates with novel therapeutic interventions being developed by the wider PBTC, 2) ensures that every PBTC protocol incorporates an imaging "end point" among its objectives, 3) promotes the widespread implementation of standardized technical protocols for neuroimaging, and 4) facilitates a quality assurance program that complies with the highest standards for image data transfer, diagnostic image quality, and data integrity. To accomplish these specific objectives, the NIC works with the various PBTC sites (10 in all, plus NCI/National Institute of Neurological Diseases and Stroke representation) to ensure that the overarching mission of the consortium-to better understand tumor biology and develop new therapies for central nervous system tumors in children-is furthered by creating a uniform body of imaging techniques, technical protocols, and standards. Since the inception of the NIC in 2003, this broader mandate has been largely accomplished through a series of site visits and meetings aimed at assessing prevailing neuroimaging practices against NIC-recommended protocols, techniques, and strategies for achieving superior image quality and executing the secure transfer of data to the central PBTC. These ongoing evaluations periodically examine investigations into targeted drug therapies. In the future, the NIC will concentrate its efforts on improving image analysis for MR imaging and positron-emission, tomography (PET) and on developing new ligands for PET; imaging markers for radiation therapy; and novel systemic, intrathecal, and intralesional therapeutic interventions.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 013273652

Download citation: RISBibTeXText

PMID: 17416804


Related references

Tmod-20. The Pediatric Brain Tumor Atlas: An Initiative By The ChildrenS Brain Tumor Tissue Consortium And Pacific Pediatric Neurooncology Consortium. Neuro-Oncology 21(Supplement_2): ii125, 2019

Gene-12. The ChildrenS Brain Tumor Tissue Consortium (Cbttc) Infrastructure Facilitates Collaborative Research In Pediatric Central Nervous System Tumors. Neuro-Oncology 19(suppl_4): iv20-iv21, 2017

Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium. Journal of Nuclear Medicine 52(2): 188-195, 2011

Exploratory evaluation of MR permeability with 18F-FDG PET mapping in pediatric brain tumors: a report from the Pediatric Brain Tumor Consortium. Journal of Nuclear Medicine 54(8): 1237-1243, 2013

Neuroimaging and neuropsychological follow-up study in a pediatric brain tumor patient treated with surgery and radiation. Neurocase 16(1): 74-90, 2010

18F-FDG PET and MR imaging associations across a spectrum of pediatric brain tumors: a report from the pediatric brain tumor consortium. Journal of Nuclear Medicine 55(9): 1473-1480, 2014

Use of a Qualification Phantom for PET Brain Imaging in a Multicenter Consortium: A Collaboration Between the Pediatric Brain Tumor Consortium and the SNMMI Clinical Trials Network. Journal of Nuclear Medicine 2018, 2018

Neuroimaging in the evaluation of suspected brain tumor recurrence in the pediatric population, the critical role of fluorodeoxyglucose positron emission tomography studies. Journal of Nuclear Medicine 38(5 SUPPL ): 12P-13P, 1997

DTI assessment of the brainstem white matter tracts in pediatric BSG before and after therapy: a report from the Pediatric Brain Tumor Consortium. Child's Nervous System 27(1): 11-18, 2011

Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study. Neuro-Oncology 14(11): 1404-1412, 2013

Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience. Cancer 112(4): 892-899, 2007

Carboplatin hypersensitivity reaction in pediatric low grade glioma (LGG) patients: A national experience. On behalf of the Canadian Pediatric Brain Tumor Consortium. Journal of Clinical Oncology 24(18_suppl): 9053-9053, 2016

Agreement between pediatric brain tumor patients and parent proxy reports regarding the Pediatric Functional Assessment of Cancer Therapy-Childhood Brain Tumor Survivors questionnaire, version 2. Cancer 116(15): 3674-3682, 2010

Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018. Journal of Clinical Oncology 29(3): 324-329, 2011

Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study. Proteomics 11(5): 935-943, 2011